Trials Sponsors Conditions Drugs Pricing

Conditions

Postoperative Complications

Outcome Measures

Primary Outcomes (4)

Number of patients with major adverse cardiovascular events
Number of participants with major adverse cardiovascular events
30rd day post-operatively
Number of patients with acute kidney injury
Number of participants with acute kidney injury according to the RIFLE (Risk, Injury, Failure, Loss of kidney function, and End-stage kidney disease) criteria
30rd day post-operatively
Number of patients with post-implantation syndrome
Number of participants with post-implantation syndrome SIRS, without any apparent sign of infection
30rd day post-operatively
Deaths of any cause
Number of participants who died from any cause
30rd day post-operatively

Study Arms (1)

EVAR

Patients with AAA, treated electively by EVAR. The 30-day postoperative outcome after elective EVAR and the role of possible predictors among patients' baseline characteristics were assessed.

Other: 30-day postoperative outcome

Interventions

30-day postoperative outcomeOther

The 30-day postoperative outcome after elective EVAR and the role of possible predictors among patients' baseline characteristics were assessed

EVAR

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

The study included consecutive AAA patients treated electively by EVAR

You may qualify if:

Only patients managed with EVAR using standard bifurcated devices in elective setting were included.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

University of Thessaly
Otherlead

Study Sites (1)

University Hospital of Larissa

Larissa, Thessaly, 41110, Greece

MeSH Terms

Conditions

Postoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

Eleni Arnaoutoglou, Professor
University of Thessaly
STUDY CHAIR

Enrollment

322 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Professor of Anesthesiology

Study Record Dates

First Submitted

November 22, 2022

First Posted

December 12, 2022

Study Start

March 23, 2016

Actual (reported)

Predictors of 30-day Postoperative Outcome After Elective EVAR

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (4)

Study Arms (1)

EVAR

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (4)

Study Arms (1)

EVAR

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations